Financials

  • Market Capitalization 2.1359 B
  • Employee 910
  • Founded 2015
  • CEO N/A
  • Website www.grail.com
  • Headquarter Delaware, United States
  • FIGI BBG01N6CGW43
  • Industry Диагностика и исследования
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Коэффициент цена/прибыль
-7.7
Коэффициент цена/денежный поток
21.37

GRAIL Inc

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021. In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.